ZellBios gets new loan and private equity owner

By Olivier Holmey
18 Dec 2013

ZellBios, which makes pharmaceutical ingredients, is raising €125m of drawn and undrawn debt to finance its buyout by Deutsche Private Equity.

The company, born of the 2011 merger of Italy’s Farmabios and Germany’s Pharmazell, previously belonged to Ergon Capital.

The all-senior buyout debt consists of a €33m term loan ‘A’, €67m term loan ‘B’, €15m revolver and €10m capex facility. The term loan ‘B’ is priced at 450bp over ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial